docetaxel anhydrous has been researched along with Cancer of Larynx in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (26.67) | 29.6817 |
| 2010's | 25 (55.56) | 24.3611 |
| 2020's | 8 (17.78) | 2.80 |
| Authors | Studies |
|---|---|
| Fukugawa, Y; Matsuyama, T; Murakami, D; Nishimoto, K; Orita, Y; Oya, N; Saito, T; Toya, R; Watakabe, T | 1 |
| Deng, H; Shen, Y; Shen, Z; Tang, M; Wei, Z; Zhou, C | 1 |
| Bellile, E; Bradford, CR; Carey, TE; Casper, K; Chinn, SB; Dragovic, AF; Eisbruch, A; Jolly, S; Kupfer, R; Malloy, KM; Mierzwa, ML; Prince, ME; Shuman, AG; Spector, ME; Srinivasan, A; Stucken, C; Swiecicki, PL; Wolf, GT; Worden, FP | 1 |
| Ding, H; Li, R; Tian, S; Wang, S; Wang, X; Wu, C; Ye, L; Ying, H; Zhou, L; Zhu, Y | 1 |
| Li-Jessen, NYK; Moya-Garcia, CR; Tabrizian, M | 1 |
| Baste, N; Berrocal-Jaime, A; Cruz-Hernández, JJ; Cunquero-Tomas, AJ; Del Barco-Morillo, E; García-Girón, C; Grau, JJ; Guix, M; Hitt, R; Iglesias, L; Lambea-Sorrosal, J; León-Vintró, X; López-Pousa, A; Martínez-Trufero, J; Ocaña, A | 1 |
| Botticelli, A; Cerbelli, B; Cirillo, A; Corsi, A; De Vincentiis, M; Di Gioia, C; Marchetti, P; Mezi, S; Polimeni, A; Pomati, G; Roberto, M; Tombolini, V; Valentini, V; Vullo, F | 1 |
| Damghani, MA; Larizadeh, MH; Mohammadi, F; Shabani, M | 1 |
| Cao, YC; Liu, DY; Wang, XY; Xu, WW | 1 |
| Beppu, S; Ijichi, K; Kabaya, K; Kawakita, D; Matoba, T; Murakami, S; Torii, J; Yanagi, T | 1 |
| Bockmühl, U; Boehm, A; Budach, V; Bünzel, J; de Wit, M; Dietz, A; Eich, HT; Esser, D; Feyer, P; Flentje, M; Foerg, T; Görner, M; Guntinas-Lichius, O; Hagen, R; Hautmann, MG; Held, S; Jungehülsing, M; Keilholz, U; Klussmann, JP; Knödler, M; Kölbl, O; Kuhnt, T; Lenarz, T; Lordick, F; Maschmeyer, G; Münter, M; Pfreundner, L; Preyer, S; Remmert, S; Rudack, C; Scheich, M; Schilling, V; Schreiber, F; Schroeder, U; Sittel, C; Strutz, J; Sudhoff, H; Thurnher, D; Vogel, K; Welkoborsky, HJ; Westhofen, M; Wichmann, G; Wiegand, S; Wollenberg, B | 1 |
| Montero, M; Stack, BC; Ye, J | 1 |
| Bakan, S; Demiryas, S; Kantarci, F; Korkmazer, B; Olgun, DC; Samanci, C; Tutar, O | 1 |
| Cheng, J; Jin, C; Liu, X; Liu, Y; Qi, X; Yang, J; Yu, D; Zhao, X | 1 |
| Agüero, A; Farré, N; García, J; León, X; López, M; López-Pousa, A; Quer, M | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Nakashima, T; Nishikawa, D; Ozawa, T; Suzuki, H | 1 |
| Chung, IJ; Joo, YE; Kim, SA; Lee, DH; Lee, JK; Lee, KH; Lim, SC; Park, YL; Yoon, TM | 1 |
| Inohara, H; Isohashi, F; Nakahara, S; Ogawa, K; Seo, Y; Sumida, I; Suzuki, O; Takenaka, Y; Tomiyama, Y; Yamamoto, Y; Yoshii, T; Yoshioka, Y | 1 |
| Berg, S; Boessert, P; Fruth, K; Haxel, BR; Mann, WJ | 1 |
| Alfonsi, M; Calais, G; Chapet, S; Garaud, P; Jadaud, E; Janoray, G; Pointreau, Y; Sire, C | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Adkins, DR; Blajman, CR; Cohen, RB; Cullen, KJ; Frenette, GP; Freue, JM; Gorbunova, VA; Haddad, RI; Mickiewicz, EA; Norris, CM; Plinar, LF; Posner, MR; Raez, LE; Roessner, MR; Shin, DM; Steinbrenner, LM; Tishler, RB; Tjulandin, SA; Winquist, EW; Wirth, LJ | 1 |
| Alfonsi, M; Calais, G; Chapet, S; Faivre, S; Garaud, P; Guerrif, S; Pointreau, Y; Sire, C; Tortochaux, J; Tuchais, C | 1 |
| Haddad, RI | 1 |
| Damghani, MA; Larizadeh, MH | 1 |
| Alieva, SB; Romanov, IS; Tiuliandin, SA; Tkachev, SI; Zaderenko, IA | 1 |
| Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
| Chilimoniuk, M; Maksimowicz, T; Olszewska, E | 1 |
| Hamano, T; Iida, M; Odagiri, K; Ohizumi, Y; Okami, K; Onuki, J; Sakai, A; Takeo, T; Tamai, Y | 1 |
| Debus, J; Desta, A; Habl, G; Jensen, AD; Krauss, J; Mavtratzas, A; Münter, MW; Potthoff, K; Windemuth-Kiesselbach, C | 1 |
| Baudin, F; Bedock, B; Blanc, PL; Guillot, P | 1 |
| Asano, A; Hirasawa, N; Horikawa, Y; Ishihara, S; Itoh, Y; Koyama, K; Murao, T; Naganawa, S; Nomoto, Y; Obata, Y; Sasaoka, M; Suzuki, K | 1 |
| Agarwal, A; Cooley, TP; Logeswaran, P; Mehta, A; Subramaniam, RM | 1 |
| Furusaka, T; Ikeda, M; Katsura, Y; Matsuda, A; Saito, T | 1 |
| Fietkau, R; Iro, H; Kuwert, T; Lell, M; Lettmaier, S; Schmidt, D; Semrau, S; Waldfahrer, F | 1 |
| Corry, J; Kleid, S; Peters, L; Rischin, D | 1 |
| Furusaka, T; Ikeda, M; Matsuda, A; Matsuda, H; Tanaka, A | 1 |
| Chihara, Y; Fujishiro, Y; Fukaya, T; Kawanabe, W; Maeda, Y | 1 |
| Busse, PM; Goguen, L; Guadagnolo, BA; Haddad, RI; Norris, CM; Posner, MR; Sullivan, CA; Tishler, R; Weeks, L; Wirth, LJ | 1 |
| Akimoto, T; Chikamatsu, K; Furuya, N; Hayakawa, K; Ishikawa, H; Kitamoto, Y; Mitsuhashi, N; Nakano, T; Ninomiya, H; Nonaka, T | 1 |
| Biete Solà, A; Calvo Manuel, FA; de Las Heras González, M; Grau de Castro, JJ; Marruecos Querol, J; Palacios Eito, A; Ramos Aguerri, A; Rovirosa Casino, A; Solano López, MV; Veiras Candal, C; Verger Fransoy, E | 1 |
| Borel, C; Calais, G; Cupissol, D; Eymard, JC; Germann, N; Kohser, F; Labourey, JL; Tourani, JM; Tubiana-Mathieu, N | 1 |
| Carcel-Trullols, J; Evans, TT; Fukuda, S; Furuta, Y; Higuchi, M; Mizumachi, T; Naito, A; Oridate, N; Spring, PM; Suzuki, S | 1 |
| Abe, K; Hiramatsu, H; Itoh, H; Nakamura, K; Okamoto, I; Shimizu, S; Suzuki, M; Takada, D; Tokashiki, R; Tsukahara, K; Yoshida, T | 1 |
| Deng, Y; Ji, W; Liu, T; Sun, C; Yang, X; Zhang, H; Zhang, M | 1 |
13 trial(s) available for docetaxel anhydrous and Cancer of Larynx
| Article | Year |
|---|---|
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Organ Preservation; Platinum; Proto-Oncogene Proteins c-bcl-2 | 2022 |
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Organ Sparing Treatments; Prognosis; Radiotherapy; Salvage Therapy; Survival Rate | 2018 |
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA, Viral; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Organ Sparing Treatments; Oropharyngeal Neoplasms; Papillomaviridae; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Stomatitis; Survival Rate; Taxoids | 2015 |
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Organ Sparing Treatments; Squamous Cell Carcinoma of Head and Neck; Taxoids; Time Factors; Treatment Outcome | 2016 |
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Taxoids; Time Factors; Treatment Outcome | 2009 |
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Karnofsky Performance Status; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome; Young Adult | 2009 |
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carbon; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Genetic Testing; Humans; Hypopharyngeal Neoplasms; Ions; Laryngeal Neoplasms; Oropharyngeal Neoplasms; Radioimmunotherapy; Taxoids | 2011 |
Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Glottis; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2013 |
Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Glottis; Humans; Infusions, Intra-Arterial; Japan; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Taxoids | 2013 |
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Dose Fractionation, Radiation; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Taxoids | 2005 |
Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Docetaxel; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Pharynx; Radiotherapy; Radiotherapy Dosage; Taxoids; Time Factors; Treatment Outcome | 2007 |
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Recurrence; Taxoids; Treatment Outcome | 2007 |
A phase I-II study of bi-weekly docetaxel combined with radiation therapy for patients with cancer of the larynx/hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Hypopharyngeal Neoplasms; Injections, Intravenous; Laryngeal Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids; Treatment Outcome | 2007 |
32 other study(ies) available for docetaxel anhydrous and Cancer of Larynx
| Article | Year |
|---|---|
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Vocal Cords | 2022 |
ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cohort Studies; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Integrins; Laryngeal Neoplasms; Male; Middle Aged; Nomograms; Prognosis; Proportional Hazards Models; Survival Analysis | 2022 |
Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Laryngectomy; Larynx; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2022 |
Chitosomes Loaded with Docetaxel as a Promising Drug Delivery System to Laryngeal Cancer Cells: An In Vitro Cytotoxic Study.
Topics: Antineoplastic Agents; Chitosan; Docetaxel; Drug Delivery Systems; Humans; Laryngeal Neoplasms; Liposomes; Particle Size | 2023 |
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Confidence Intervals; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Intention to Treat Analysis; Laryngeal Neoplasms; Mouth Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Tumor Burden | 2021 |
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Papillomavirus Infections; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2020 |
Induction Chemotherapy Followed by either Chemoradiotherapy or Bioradiotherapy in Laryngeal Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Prognosis; Survival Rate | 2021 |
GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Hep G2 Cells; Humans; Laryngeal Neoplasms; Lipid Bilayers; Liposomes; Mice, Nude; Nanoparticles; Neoplasm Proteins; Peptides; RNA, Small Interfering; Static Electricity; Taxoids; Xenograft Model Antitumor Assays | 2017 |
Chemo-selection with docetaxel, cisplatin and 5-fluorouracil (TPF) regimen followed by radiation therapy or surgery for pharyngeal and laryngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Retrospective Studies; Taxoids | 2017 |
Effects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Survival; Cytokines; Docetaxel; Drug Resistance, Neoplasm; Fusaric Acid; Humans; Laryngeal Neoplasms; Poly(ADP-ribose) Polymerases; Taxoids; Time Factors | 2013 |
Simultaneous thrombosis of superior mesenteric artery and superior mesenteric vein following chemotherapy: MDCT findings.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Mesenteric Artery, Superior; Mesenteric Veins; Multidetector Computed Tomography; Taxoids; Thrombosis; Venous Thrombosis | 2014 |
Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Topics: AC133 Antigen; Animals; Antigens, CD; Carboplatin; Carcinogenesis; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Laryngeal Neoplasms; Mice; Neoplastic Stem Cells; Peptides; Polycomb Repressive Complex 1; Taxoids | 2015 |
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; Docetaxel; Early Growth Response Protein 1; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Immediate-Early; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Proteins; Organ Sparing Treatments; Photons; Radiation Tolerance; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Taxoids; Transfection | 2015 |
Olfaction in chemotherapy for head and neck malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Controlled Before-After Studies; Differential Threshold; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Olfaction Disorders; Pharyngeal Neoplasms; Prospective Studies; Sensory Thresholds; Smoking; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2016 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Re: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Fluorouracil; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Recovery of Function; Remission Induction; Taxoids | 2009 |
Sequential chemoradiotherapy in advanced laryngeal cancer: an institutional experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Taxoids | 2010 |
[Docetaxel as a component in the combined therapy of locally advanced squamous cell carcinoma of the glottis and oral cavity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Glottis; Humans; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Platinum Compounds; Radiotherapy, Adjuvant; Taxoids; Treatment Outcome | 2010 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Neutropenia; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Vomiting | 2010 |
Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Humans; Laryngeal Neoplasms; Male; Recurrence; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2008 |
[Refractory thrombotic thrombocytopenic purpura revealing an epiglotis neoplasia].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Epiglottis; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Rituximab; Taxoids; Vitamin B 12; Vitamins | 2012 |
Multi-institutional analysis of early glottic cancer from 2000 to 2005.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Tegafur; Time Factors; Uracil | 2012 |
Radiology quiz case 2. Docetaxel (Taxotere)-induced photosensitivity.
Topics: Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Follow-Up Studies; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Parotid Neoplasms; Photosensitivity Disorders; Positron-Emission Tomography; Radiosurgery; Risk Assessment; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Endoscopy; Feasibility Studies; Female; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Pharyngeal Neoplasms; Positron-Emission Tomography; Remission Induction; Salvage Therapy; Survival Rate; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Larynx preservation for patients with locally advanced laryngeal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Hoarseness; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organ Sparing Treatments; Smoking; Smoking Cessation; Taxoids; Treatment Outcome; Vocal Cords; Xerostomia | 2013 |
[A case of pulmonary metastases from laryngeal cancer showing a complete response to chemotherapy with docetaxel].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Taxoids | 2004 |
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Voice Quality | 2006 |
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA, Mitochondrial; Docetaxel; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Laryngeal Neoplasms; Oligomycins; Proton-Translocating ATPases; Reactive Oxygen Species; RNA Interference; Taxoids | 2008 |
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Docetaxel; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Laryngeal Neoplasms; Microscopy, Fluorescence; Neoplasm Proteins; Neoplasm Transplantation; Signal Transduction; Taxoids; Triterpenes; Xenograft Model Antitumor Assays | 2008 |